PharmaShots | Incisive News in 3 Shots

Subscribe Now

First Tumor Agonist

Bayer's Vitrakvi (larotrectinib) Receives EMA's Approval as the First Tumor Agonist in Europe

Bayer's Vitrakvi (larotrectinib) Receives EMA's Approval as the First Tumor Agonist in Europe

September 24, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us